MNKD (MannKind Corporation) Short-Term Debt to Capital

Corporate company logo of MannKind Corporation (MNKD)

MannKind Corporation (MNKD) operates its own US-based manufacturing facility to produce innovative drug delivery systems and inhalers. The business monetizes its unique Technosphere platform through licensing agreements with industry behemoths and the development of orphan drugs. This price chart featuring the 0.00 indicator confirms growth potential amid rising demand for convenient therapies for diabetes and pulmonary pathologies.

Ratio of Short-Term Indebtedness to Capital: MannKind Corp. (MNKD) for 07/04/2022 - 11/01/2026

Analytical breakdowns for MannKind Corporation

- stock quotes and analyst forecast:
Stock Price MannKind Corp.|MNKD - Fair Value Consensus
- business market valuation indicators:
Market Capitalization MannKind Corp|MNKD - Enterprise Value
- book capitalization information:
Net Assets per Single Share MannKind|MNKD - Accounting Value of Company|Market Value to Book Value Ratio mannkindcorp.com|MNKD - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital MannKind Corporation|MNKD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio MannKind|MNKD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio MannKind Corp|MNKD - Long-Term Debt|Company Current Liabilities MannKind|Quick Ratio mannkindcorp.com
- company profitability and valuation multiples indicators:
MNKD - Final Profit
Fundamental valuation:MNKD MannKind Corp.
Brand item of MannKind Corp

For MannKind Corporation (MNKD), the current short-term debt-to-equity chart reflects the dependence of inhaler supplies on operational liquidity amid geopolitical instability and logistics disruptions. The ratio of liabilities maturing within one year to equity measures the risk of excessive reliance on "fast" leverage, allowing investors to assess the resilience of the company's balance sheet to a sudden contraction of sales markets.

Competitors of MannKind Corporation (MNKD)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|AMPH (Amphastar Pharmaceuticals Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Pacira PCRX|ARS Corp (SPRY) - Current Liabilities to Capital|TBPH: Short-Term Debt to Equity Ratio|aquestive.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity eXoZymes EXOZ|ORMP - Short-Term Debt to Equity Ratio|Entera Bio Corp - Short-Term Debt to Capital|HYFT - Short-Term Debt to Capital|ABVC BioPharma (ABVC) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio CPIX|Short-Term Debt to Equity Quantum BioPharma|Short-Term Debt to Capital Ratio FGEN (FibroGen Inc)|Short-Term Debt to Equity Telomir Pharma (TELO)|Short-Term Debt to Capital ranitherapeutics.com (RANI)|Short-Term Debt to Capital SNYR (Synergy CHC)|Short-Term Debt to Capital Coefficient Rallybio Corp (RLYB)|LEXX - Short-Term Debt to Equity|PULM (Pulmatrix Inc) - Short-Term Debt to Capital Ratio|PTHL: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio APM|Short-Term Debt to Equity Ratio LYRA|IBO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TNFA|Short-Term Debt to Equity Ratio cbdmd.com YCBD|Short-Term Debt to Equity PainReform Limited PRFX|Altamira Therapeutics Ltd (CYTO) - Current Liabilities to Capital|LIPO - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital OPTN (optinose.com)|Pieris Pharmaceuticals, Inc. (PIRS) - Short-Term Debt to Equity|Current Liabilities to Equity PROC (Procaps Group)|Short-Term Debt to Equity Petros|Current Liabilities to Capital Qilian International Corp QLI|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP (tffpharma.com) - Ratio of Short-Term Indebtedness to Capital